N7H-28963-14045
2 vaccinations
6 coded responses
21 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 482 / MI
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Dose 1 — Pfizer-BioNTech
-
2021-01-07
Registered in v-safe
-
2021-01-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-01-08
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-08
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-09
-
2021-01-11
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-11
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-20
- 2021-01-26
-
2021-01-29
Dose 2 — Pfizer-BioNTech
- 2021-01-29
- 2021-01-31
-
2021-02-01
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain — Feeling: Fair · Site: PainFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-02
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: Good · Site: PainFree text: Sore throat, runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-03
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: GoodFree text: Runny nose, sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-04
- 2021-02-05
-
2021-02-12
Survey response — day 14, dose 2MedDRA: Migraine — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Intractable migrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-05-02
-
2021-07-30
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-01-29
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: FairFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Pfizer-BioNTech | |
| 2 | 2021-01-29 | Pfizer-BioNTech |
Call center
2 call center cases
2 priority 2/3 (triaged and no follow up)
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Sore throat
Systemic reaction (other): Sore throat, runny nose
Systemic reaction (other): Runny nose, sore throat
Release 4 — day 14, dose 2
Symptoms: Intractable migraines
Release 9 — 6 months, dose 2
Symptoms: Pregnancy
Release 11 — 12 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release